The global pharma ADMET testing market is booming, projected at $1.5 Billion in 2025 and growing at a 5% CAGR. This in-depth analysis explores market trends, key players (Charles River, WuXi AppTec, IQVIA), regional growth (North America, Europe, Asia Pacific), and the crucial role of in vitro and in vivo testing in drug development. Discover the latest insights and future projections for this vital sector.
We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.
